Search

Your search keyword '"Simona Leoni"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Simona Leoni" Remove constraint Author: "Simona Leoni"
57 results on '"Simona Leoni"'

Search Results

1. PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY

2. Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease

3. Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients

4. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

5. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

6. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications

7. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

8. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

9. Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

10. Viral hepatitis: Innovations and expectations

11. Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

12. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

13. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge

14. Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience

15. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

16. Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects

17. Treatment of Combined Hepatocellular and Cholangiocarcinoma

18. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

19. Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)

20. Moderate alcohol consumption is associated with risk of fibrosis in patients with non-alcoholic fatty liver disease

21. Pain and Frailty in Hospitalized Older Adults

22. History of Nonalcoholic Fatty Liver Disease

23. Risk factors for significant fibrosis differently affect patients with non-alcoholic liver disease depending on gender

24. Subtle changes of c-reactive protein and serum creatinine during the index hospitalization predict early readmission in patients with decompensated cirrhosis

25. LncRNAs as novel players in hepatocellular carcinoma recurrence

26. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules

27. Contrast-enhanced ultrasound in liver cancer

28. Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group

30. Treatment of hepatocellular carcinoma in Child-Pugh B patients

31. The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria

32. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system

33. The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives

34. Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma

35. CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodules

36. A Case of Antibiotic-Resistant Dorsal Hand Purulent Tenosynovitis Diagnosed by Ultrasound Post Liver Transplant

38. Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography

39. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?

40. Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved

41. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound

42. Response rate and clinical outcome of HCC after first and repeated cTACE performed 'on demand'

43. Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma

44. Contrast enhanced ultrasound in diagnosis of hepatocellular carcinoma (HCC): role of wash-out in portal and late phases

45. Characterization of liver lesions by real-time contrast-enhanced ultrasonography

46. Survival of patients with hepatocellular carcinoma (HCC) within the Bologna Liver Oncology Group: comparison with international guidelines

47. Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis

48. Caution in the use of boldo in herbal laxatives: a case of hepatotoxicity

49. Clinico-Pathological Classification

50. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension

Catalog

Books, media, physical & digital resources